Related Experiment Videos
Risks for and prevention of infective endocarditis
1Department of Medicine, University of California Los Angeles School of Medicine, USA.
Insights
Physicians must identify patients at risk for bacterial endocarditis and educate them on prophylaxis. Patient awareness of this preventable heart infection is crucial for reducing severe outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Preventive Medicine
Background:
- Bacterial endocarditis is a severe, often fatal, infection requiring prevention in at-risk patients.
- Patients with congenital or acquired cardiac conditions often lack awareness regarding necessary endocarditis prophylaxis.
- Physicians play a critical role in identifying susceptible patients and educating them on preventive measures.
Purpose of the Study:
- To emphasize the importance of bacterial endocarditis prophylaxis in susceptible patient populations.
- To highlight the gap in patient awareness regarding the need for endocarditis prevention.
- To underscore the physician's responsibility in patient education and prophylaxis determination.
Main Methods:
- Review of current medical practices for bacterial endocarditis prevention.
- Analysis of American Heart Association guidelines for endocarditis prophylaxis.
- Consideration of clinical experience, in vitro studies, and animal models for recommendations.
Main Results:
- A significant portion of patients, particularly those unaware of pre-existing heart disease, are not eligible for chemoprophylaxis, leading to preventable cases.
- Recommendations for prophylaxis are based on a combination of evidence, not solely on human clinical trials.
- Physician-led patient education and risk assessment are key components of preventive strategy.
Conclusions:
- Preventing even a small number of bacterial endocarditis cases is vital due to the condition's high morbidity and mortality.
- Enhanced patient and physician awareness can improve the efficacy of endocarditis prevention strategies.
- Clinical judgment, supplemented by guidelines, is essential for tailoring endocarditis prophylaxis.
Abstract:
It is accepted medical practice to prevent bacterial endocarditis in patients with susceptible congenital or acquired cardiac malformations who are likely to experience predictable procedure-related bacteremia. Patients in general, those with congenital heart disease specifically, are insufficiently aware of the need for such prophylaxis. It is responsibility of the physician to determine which patients are susceptible to endocarditis and the need for endocarditis prophylaxis for each patient for any given instance and to educate the patient as to this need. The American Heart Association provides wallet-sized cards that may be given to each patient. Those patients not previously known to have heart disease are, of course, not eligible for chemoprophylaxis. Because these represent many of the patients with endocarditis each year, it can be argued that only a minority of patients have preventable cases. Regarding the clinical application of anti-infective endocarditis prophylaxis, the American Heart Association gives this perspective: This statement represents recommended guidelines to supplement practitioners in the exercise of their clinical judgement and is not intended as a standard of care for all cases.... Because no adequate, controlled clinical trials of antibiotic regimens for the prevention of bacteria endocarditis in humans have been done, recommendations are based on vitro studies, clinical experience, data from experimental animal models, and assessment of both the bacteria most likely to produce bacteremia from a given site and those most likely to result in endocarditis. Bacterial endocarditis is one of the few infectious disease that almost always result in death unless treated. The dramatic nature of the morbidity and mortality of infective endocarditis in those so afflicted makes the prevention of even a few cases worth the effort.